TUBERCULOSIS TREATMENT

New, shorter regimen for drug-resistant TB offers hope

"We are administering BPaLM to carefully selected patients in line with national guidelines," said Dr Priti Meshram, Head of Pulmonary Medicine at JJ Hospital.

More in TUBERCULOSIS TREATMENT

Researchers give new insight into tuberculosis treatment

Some of the found compounds may enable the re-treatment of tuberculosis with existing treatments, including strains of the bacterium that have already established drug resistance.
ICMR study to assess efficacy of 4-month tuberculosis treatment regimen underway

The whole idea of shortening the treatment is just not cure, but to see that the patients do not have recurrence of disease. That is the principle of shortening treatment, Dr Priyadarshini said.
Study finds common antibiotic useful in accelerating recovery in tuberculosis patients

The study findings were published in the Journal of Clinical Investigation.
New J&J TB drug not without side effects: Sir John Walker

The 1997 Nobel winner in chemistry, who was one of the speakers at the Lindau Nobel Laureates meeting, said clinical data showed that the drug has side effects.
J&J working with government on tuberculosis treatment

Last year, Telangana Government had said that it has entered into an MoU with Johnson & Johnson to work together for making the state tuberculosis free.